diphenyl has been researched along with losartan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bruno, C; Carocci, A; Catalano, A; Di Mola, A; Franchini, C; Vanderheyden, PM | 1 |
| Nagahama, M; Seki, M | 1 |
| Doddipalla, R; Gandham, H; Geereddy, MKR; Jayanti, NM; Kaliyaperumal, M; Rumalla, CS; Singamsetti, JM | 1 |
3 other study(ies) available for diphenyl and losartan
| Article | Year |
|---|---|
1-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-pyrrolidine-2-carboxamide: investigation of structural variations.
Topics: Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; CHO Cells; Cricetinae; Humans; Ligands; Losartan; Molecular Structure; Protein Binding; Pyrrolidines; Receptor, Angiotensin, Type 1; Tetrazoles | 2011 |
Synthesis of angiotensin II receptor blockers by means of a catalytic system for C-H activation.
Topics: Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Catalysis; Chelating Agents; Humans; Losartan; Magnetic Resonance Spectroscopy; Ruthenium; Tetrazoles; Tetrazolium Salts; Valine; Valsartan | 2011 |
Isolation and structural characterization of two novel oxidative degradation products of losartan potassium active pharmaceutical ingredient using advanced analytical techniques.
Topics: Biphenyl Compounds; Chromatography, High Pressure Liquid; Drug Stability; Losartan; Oxidative Stress; Pharmaceutical Preparations | 2023 |